Chenggong Li
- Topics
- CAR-T cell therapy research (28 papers)Immune Cell Function and Interaction (4 papers)Biosimilars and Bioanalytical Methods (4 papers)
- Cited by
- OncologyHematologyImmunology
- Journals
- SHILAP Revista de lepidopterologíaBloodCell Death and Differentiation
- Partner nations
- ChinaSpainUnited States
In The Last Decade
Chenggong Li
33 papers receiving 562 citations
Peers
Comparison fields: 5 of 54
- Oncology 399
- Molecular Biology 247
- Genetics 121
- Biomedical Engineering 106
- Immunology 106
Countries citing papers authored by Chenggong Li
This map shows the geographic impact of Chenggong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenggong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenggong Li more than expected).
Fields of papers citing papers by Chenggong Li
This network shows the impact of papers produced by Chenggong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenggong Li. The network helps show where Chenggong Li may publish in the future.
Co-authorship network of co-authors of Chenggong Li
This figure shows the co-authorship network connecting the top 25 collaborators of Chenggong Li. A scholar is included among the top collaborators of Chenggong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenggong Li. Chenggong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 52 | |
| 7 | 19 | |
| 8 | 0 | |
| 9 | 14 | |
| 10 | 45 | |
| 11 | 35 | |
| 12 | 6 | |
| 13 | 1 | |
| 14 | 13 | |
| 15 | 64 | |
| 16 | 14 | |
| 17 | 67 | |
| 18 | 10 | |
| 19 | 78 | |
| 20 | 1 |
About Chenggong Li
Chenggong Li is a scholar working on Oncology, Hematology and Immunology, having authored 36 papers that have together received 566 indexed citations. Recurring topics across this work include CAR-T cell therapy research (28 papers), Immune Cell Function and Interaction (4 papers) and Biosimilars and Bioanalytical Methods (4 papers). The work is most often cited by research in Oncology (399 citations), Hematology (85 citations) and Immunology (106 citations). Chenggong Li has collaborated with scholars based in China, Spain and United States. Frequent co-authors include Heng Mei, Yu Hu, Yu Hu, Wenjing Luo, Huiwen Jiang, Jun Deng, Yinqiang Zhang, Lu Tang, Lin Liu and Yaohui Wu. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.